SPOTLIGHT -
Bausch + Lomb, Novaliq publish pivotal Phase 3 data on NOV03
The importance of ocular health prior to cataract and refractive surgery
Cataract surgery reimbursements may not be enough for some patients
Commercial real estate and your practice, part two with Colin Carr
Aurion Biotech receives approval from Japan’s PMDA for New Drug Application
Visus Therapeutics completes enrollment in BRIO-I Phase 3 clinical trial of Brimochol PF for the treatment of presbyopia
